Home > Research > Browse

Results for Long-Term Potentiation

Publications & Outputs

  1. Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease

    McClean, P. L. & Holscher, C., 11/2014, In : Neuropharmacology. 86, p. 241-258 18 p.

    Research output: Contribution to journalJournal article

  2. Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats

    Han, W-N., Hölscher, C., Yuan, L., Yang, W., Wang, X-H., Wu, M-N. & Qi, J-S., 02/2013, In : Neurobiology of Aging. 34, 2, p. 576-588 13 p.

    Research output: Contribution to journalJournal article

  3. Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice

    Faivre, E., Hamilton, A. & Hölscher, C., 15/01/2012, In : European Journal of Pharmacology. 674, 2-3, p. 294-306 13 p.

    Research output: Contribution to journalJournal article

  4. Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis

    Faivre, E., Gault, V. A., Thorens, B. & Hölscher, C., 1/04/2011, In : Journal of Neurophysiology. 105, 4, p. 1574-1580 7 p.

    Research output: Contribution to journalJournal article

  5. Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice

    Porter, D. W., Irwin, N., Flatt, P. R., Hölscher, C. & Gault, V. A., 15/01/2011, In : European Journal of Pharmacology. 650, 2-3, p. 688-693 6 p.

    Research output: Contribution to journalJournal article

  6. Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease

    McClean, P. L., Gault, V. A., Harriott, P. & Hölscher, C., 25/03/2010, In : European Journal of Pharmacology. 630, 1-3, p. 158-162 5 p.

    Research output: Contribution to journalJournal article